Sun Pharma launches cancer drug in US market
NEW DELHI: Drug major Sun Pharmaceutical Industries on Monday announced launch of INFUGEM injection, used for treatment of cancer, in the US market. In July 2018, Sun Pharma had received approval from the US health regulator for INFUGEM injection. “INFUGEM (gemcitabine in sodium chloride injection), for intravenous use, is now commercially available in the US,” […]